FDA Inspection 1074969 — Nanjing Xingyin Pharmaceutical Group Co. Ltd.
The FDA completed an inspection of Nanjing Xingyin Pharmaceutical Group Co. Ltd. on November 9, 2018 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 9, 2018
- Fiscal Year
- 2019
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Nanjing (China)